Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

György Jermendy

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Orvosi Hetilap|September 7, 2011
[Dipeptidyl-peptidase-4 inhibitors (gliptins): a new class of oral antidiabetic drugs]György Jermendy
Orvosi Hetilap|April 5, 2005
[Evidence based therapy with insulin in diabetic patients]György Jermendy
Orvosi Hetilap|April 17, 2018
[Randomized, controlled clinical trials with observational follow-up investigations for evaluating efficacy of antihyperglycaemic treatment. II. Features of and lessons from the follow-up investigations]György Jermendy
Orvosi Hetilap|March 29, 2016
[Incretin-based antidiabetic treatment and diseases of the pancreas (pancreatitis, pancreas carcinoma)]György Jermendy
Orvosi Hetilap|November 26, 2010
[New clinical data with metformin therapy in patients with diabetes mellitus]György Jermendy
Cardiovascular Diabetology|May 2, 2012
Vascular memory: can we broaden the concept of the metabolic memory?György Jermendy
Orvosi Hetilap|April 12, 2016
[Cardiovascular safety of incretin-based antidiabetic treatment - results of completed clinical trials]György Jermendy
Diabetes Research and Clinical Practice|June 16, 2005
Can type 2 diabetes mellitus be considered preventable?György Jermendy
Orvosi Hetilap|April 11, 2018
[Randomized, controlled clinical trials with observational follow-up investigations for evaluating efficacy of antihyperglycaemic treatment. I. Main results of the studies]György Jermendy
Orvosi Hetilap|November 11, 2011
[Incretin-based therapy for treating patients with type 2 diabetes]György Jermendy
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Orvosi Hetilap|September 7, 2011
[Dipeptidyl-peptidase-4 inhibitors (gliptins): a new class of oral antidiabetic drugs]György Jermendy
Orvosi Hetilap|April 5, 2005
[Evidence based therapy with insulin in diabetic patients]György Jermendy
Orvosi Hetilap|April 17, 2018
[Randomized, controlled clinical trials with observational follow-up investigations for evaluating efficacy of antihyperglycaemic treatment. II. Features of and lessons from the follow-up investigations]György Jermendy
Orvosi Hetilap|March 29, 2016
[Incretin-based antidiabetic treatment and diseases of the pancreas (pancreatitis, pancreas carcinoma)]György Jermendy
Orvosi Hetilap|November 26, 2010
[New clinical data with metformin therapy in patients with diabetes mellitus]György Jermendy
Cardiovascular Diabetology|May 2, 2012
Vascular memory: can we broaden the concept of the metabolic memory?György Jermendy
Orvosi Hetilap|April 12, 2016
[Cardiovascular safety of incretin-based antidiabetic treatment - results of completed clinical trials]György Jermendy
Diabetes Research and Clinical Practice|June 16, 2005
Can type 2 diabetes mellitus be considered preventable?György Jermendy
Orvosi Hetilap|April 11, 2018
[Randomized, controlled clinical trials with observational follow-up investigations for evaluating efficacy of antihyperglycaemic treatment. I. Main results of the studies]György Jermendy
Orvosi Hetilap|November 11, 2011
[Incretin-based therapy for treating patients with type 2 diabetes]György Jermendy
Pageof 10